genetic testing

See the following -

Apple Announces Advancements to ResearchKit

Press Release | Apple | March 21, 2016

Apple today announced advancements to the open source ResearchKit framework that bring genetic data and a series of medical tests typically conducted in an exam room to iPhone apps. Medical researchers are adopting these new features to design targeted studies for diseases and conditions that affect billions of people around the world and to gather more specific types of data from participants. “The response to ResearchKit has been fantastic. Virtually overnight, many ResearchKit studies became the largest in history and researchers are gaining insights and making discoveries that weren’t possible before,” said Jeff Williams, Apple’s chief operating officer...

Read More »

FDA Tells Google-Backed 23andMe to Halt DNA Test Service

Anna Edney | Bloomberg News | November 25, 2013

23andMe Inc., the Google Inc.-backed DNA analysis company co-founded by Anne Wojcicki, was told by U.S. regulators to halt sales of its main product because it’s being sold without “marketing clearance or approval.” Read More »

Open Access Genetic Screening for Hereditary Breast Cancer Is Feasible and Effective

Press Release | European Society of Human Genetics | May 26, 2017

Ashkenazi Jewish women are known to have a predisposition to the inherited breast cancers BRCA1 and BRCA2, but currently genetic testing in this group is limited to women affected by breast and ovarian cancers and those who are unaffected but have a family history of the disease. Ms Sari Lieberman, a genetic counsellor at the Shaare Zedek Medical Centre, Jerusalem, Israel, will tell the annual conference of the European Society of Human Genetics tomorrow (Sunday) that offering open-access BRCA testing to Ashkenazi women unaffected by cancer, regardless of their family history, enables the identification of carriers who would otherwise have been missed...

Read More »

Precision Medicine Can Save More Lives and Waste Less Money

Andy Oram | EMR & HIPPA | August 10, 2016

Andy OramThe previous section of this article looked at how little help we getfrom genetic testing. Admittedly, when treatments have been associated with genetic factors, testing has often been the difference between life and death. Sometimes doctors can hone in with laser accuracy on a treatment that works for someone because a genetic test shows that he or she will respond to that treatment. Hopefully, the number of treatments that we can associate with tests will grow over time. So genetics holds promise, but behavioral and environmental data are what we can use right now...

Read More »

Public Health Tech: The Future of Health Tech You Never Heard Of

Marquesa Finch, MPH | The Doctor Weighs In | January 29, 2017

Digital Health has experienced a glorious boom in the last decade and is expected to reach $379.3 Billion by 2024 with 25% of the growth occurring between 2016 and 2024. Patient management can now be done on user-friendly platforms; physicians can remotely monitor their patients with mobile devices and telemedicine; and personal trackers and genetic testing are allowing patients easier access to their own health data. Clearly, we understand the kind of power technology has on improving the delivery of care and management of disease...

Read More »

Stanford Medicine Launches Health Care Trends Report

Press Release | Standford Medicine | June 19, 2017

Stanford Medicine today published its inaugural Health Trends Report, a comprehensive review and analysis of existing health care research and open-source data, combined with insights from Stanford faculty and external health care experts, on the current and emerging trends facing the health care sector. The report, which will be published annually, found the promise and challenge of big data to be the most important forces driving change and improvements across health care...

Read More »

The Not-So-Precise Side of Precision Medicine

Jessica Davis | Healthcare IT News | November 7, 2016

The launch of the Precision Medicine Initiative in 2015, along with this year's Cancer Moonshot, have touted the promise of genomic data for population health and more personalized diagnosis. As a result, more consumers are seeking genetic testing and more researchers are contributing to these initiatives. But the healthcare industry isn't necessarily prepared for this shift. The popularity of genetic testing doesn't come without risks, according to Mayo Clinic's recent report, The Promise and Peril of Precision Medicine...

Read More »